Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02087852 · ClinicalTrials.gov registry record
Kidney Cancer DNA Registry
A clinical trial of Renal Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 750
- Enrollment target
- 7
- Study locations
NCT02087852: Recruiting study of Renal Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02087852 is a study of Renal Cancer that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 750 participants, above the 584-participant average among 29 other Renal Cancer trials with a reported enrollment target (28% higher). The trial reports 7 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02087852, a study of Renal Cancer, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 750 participants
- Enrollment target
- 7
- Study locations
Study Summary
This registry will help us develop better methods of: * Preventing these cancers * Diagnosing these cancers * Treating these cancers
Primary Outcome
with detailed epidemiologic data and germline DNA available for next generation sequencing from consenting patients, selected family members, and healthy unrelated controls.
Conditions Studied
Interventions
- OTHER Blood draw
- OTHER salvia for germline DNA
- BEHAVIORAL the Kidney Cancer Questionnaire
- BEHAVIORAL Family History Questionnaire (when applicable)
- BEHAVIORAL Epidemiologic Questionnaire
Study Locations (7)
New York
- Memorial Sloan Kettering Commack (Consent and Follow-up) - Commack
- Memorial Sloan Kettering Westchester (Consent and Follow up) - Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
- Memorial Sloan Kettering Nassau (Consent and Follow-Up) - Uniondale
New Jersey
- Memorial Sloan Kettering at Basking Ridge (Consent and Follow-up) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent and Follow up) - Middletown
- Memorial Sloan Kettering Bergen (Consent and Follow up ) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2014-03 |
| Est. Completion | 2026-03 |
What NCT02087852 shows while recruiting
NCT02087852 is an observational study that tracks outcomes without assigning an intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap, above the 584-participant average among 29 other Renal Cancer trials with a reported enrollment target (28% higher).
The record links to 1 condition, with Renal Cancer appearing as the primary indexed condition, and to 5 interventions - of which Blood draw is the first listed.
NCT02087852 lists 7 locations in 2 states (New York, New Jersey).
Frequently Asked Questions
What is clinical trial NCT02087852 about?
NCT02087852 is a clinical study titled "Kidney Cancer DNA Registry". This registry will help us develop better methods of: * Preventing these cancers * Diagnosing these cancers * Treating these cancers
What is the current status of trial NCT02087852?
This trial is currently recruiting. The enrollment target is 750 participants. The study started on 2014-03. Estimated completion is 2026-03.
What conditions does trial NCT02087852 study?
This clinical trial studies the following conditions: Renal Cancer.
What interventions are being tested in trial NCT02087852?
The interventions under investigation include: Blood draw (OTHER), salvia for germline DNA (OTHER), the Kidney Cancer Questionnaire (BEHAVIORAL), Family History Questionnaire (when applicable) (BEHAVIORAL), Epidemiologic Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT02087852?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02087852 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02087852's enrollment target sits among peer trials
750 4th of 29 higher than 26 of 29 other Renal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Renal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
-
Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
RECRUITING
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
RECRUITING · Phase 1
-
Advanced Diffusion Imaging in Renal Cancer Patients
RECRUITING · NA
-
A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- NCT04723095 · 750 participants
Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia